An edition of Integrated cardiac safety (2008)
Integrated cardiac safety
assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance
By J. Rick Turner
Publish Date
2009
Publisher
John Wiley & Sons
Language
eng
Pages
485
Description:
The serious nature of cardiovascular adverse drug reactions occurring in patients makes assessment of a drug's cardiac safety profile a high priority during both development and post-approval monitoring. Integrated Cardiac Safety provides necessary guidance and methodology for professionals assessing cardiac safety of drugs throughout all stages of the drug's life, from discovery and development through postmarketing research. This self-contained, reader-friendly text is valuable to professionals in the pharmaceutical, biotechnology, and CRO industries, pharmacologists, toxicologists, governm.
subjects: Cardiovascular Diseases, Cardiovascular toxicology, Drug Design, Drugs, Effect of drugs on, Heart, Medication errors, Methods, Postmarketing Product Surveillance, Prevention & control, Safety Management, Safety measures, Side effects, Testing, Toxicology, Drugs, side effects, Cardiovascular system, diseases, Drugs, design, Medical errors, Prevention and control